GM

U.S. States Join Gov. Probe of Bayer-Monsanto, Dow-DuPont Mergers

Several U.S. state attorneys general will join the pending federal antitrust investigations into the multi-billion dollar mergers between Bayer and Monsanto, and Dow and DuPont. [1]
The attorneys general will be able to provide data on how the prospective mergers – which are expected to be approved – would affect their jurisdictions and jointly conduct calls to gather information from the companies, their opponents, and supporters of the deals.

A Proposed Trial of GMO Mosquitoes Divided Voters in Florida

Residents of the Florida Keys are at odds over whether a trial of GMO mosquitoes should move forward in the area. [1]
The proposed trial would take place in Key Haven, where the people of that community voted against the mosquitoes’ release on November 8. Sixty-five percent of voters shot down the ballot measure. However, 58% of voters in Monroe County favored the test. The final decision will go to the Florida Keys Mosquito Control Board. [2]

USDA Approves 2 New Types of GMO Potatoes

Two new types of genetically modified (GM) potatoes were approved by the U.S. Department of Agriculture (USDA) on October 28. The GM potatoes are designed to resist the pathogen that caused the Irish potato famine.
Source: PotatoPro.com
The approval covers Idaho-based J.R. Simplot Co.’s Ranger Russet and Atlantic varieties of the company’s 2nd generation of Innate potatoes.

Monsanto Gets the First CRISPR License to Modify Crops

Monsanto announced last week that it licensed the CRISPR-Cas9 gene-editing tool from the Broad Institute in Boston for use in seed development. The technology will allow the agritech giant to edit crops’ DNA by “snipping” away undesirable traits – or adding in more desirable ones – of the plants’ genetic codes. Frankenfood? [1]
Source: Business Insider

Biotech Giants Bayer and Monsanto Sign Mammoth Merger Agreement

The agritech world got a lot bigger this week when German chemical giant Bayer inked an agreement to acquire Monsanto for $66 billion in cash. The 2 companies had been bickering for months, and this was the 3rd refurbished offer. In the end, Bayer agreed to pay $128 per share, up from the company’s previous offer of $127.50. [1]
The agreement makes it the largest all-cash deal on record.
Markus Manns of Union Investment, one of Bayer’s top 12 investors, said:

Scientist ‘Makes History’ by Eating 1st-Ever CRISPR Gene-Edited Meal

A lot of people are willing to spend a few extra bucks to buy organic produce and antibiotic-free meat these days, while others aren’t too worried about eating foods made with genetically modified ingredients or sprayed with pesticides. Well, it seems that scientists recently made history when they served up – and ate – the first full-meal consisting of genetically engineered food using CRISPR technology.